The ACE2 cleavage leads to the loss of ACE2 protection against RAS and increases the plasma levels of ACE2, which is considered a marker of risk for cardiovascular disease (Oudit et al., 2003). This evidence concerns the gene ACE2 and cardiovascular disorder.